Latest 10-K annual reports

Envirotech Vehicles reports a net loss of $8.8 million for 2024 amid evolving market conditions and policy uncertainties in the electric vehicle sector.

Elite Performance Holding Corp.'s 10-K filing highlights the company's commitment to ethical business practices, regulatory compliance, and transparent financial reporting, while also addressing risk factors and future growth strategies.

Bowen Acquisition Corp reports a net income of $2.96 million for 2024 but expresses substantial doubt about its ability to continue as a going concern due to significant costs and working capital deficit.

Kuber Resources Corporation's 2024 10-K filing reveals increased revenue, the acquisition of Gongfa Materials, and a shift in business focus to wood treatment.

Veea Inc. outlines the specifics of its common stock, preferred stock authorization, and warrant agreements in its latest 10-K filing, providing investors with a detailed look at its capital structure.

XTI Aerospace details its 2024 financial performance, highlighting ongoing development of the TriFan 600 and strategic shifts in its RTLS business.

Trio Petroleum Corp. files an amendment to its annual report to address SEC comments, update auditor's consent, and include new certifications, with no impact on previously reported financial figures.

BioRegenx, Inc. reports a substantial net loss of $23.05 million for the year ended December 31, 2024, driven by decreased sales, amortization and impairment expenses.

La Rosa Holdings Corp.'s 2024 annual report reveals a net loss and an auditor's concern about the company's ability to continue as a going concern, despite revenue growth and strategic acquisitions.

Sharps Technology, Inc. files an amendment to its annual report on Form 10-K to include the company's Compensation Recovery Policy.

Apimeds Pharmaceuticals US, Inc. outlines its capital stock, voting rights, and regulatory environment in its annual report, emphasizing its focus on developing Apitox for osteoarthritis and multiple sclerosis.

Western Uranium & Vanadium Corp.'s 2024 10-K filing highlights strategic investments in mining operations and processing facilities amid fluctuating uranium prices and geopolitical uncertainties.

CirTran Corporation's 2024 annual report reveals a net loss and going concern uncertainty, despite revenue from Hustler-branded products.

Groovy Company, Inc. (formerly Santo Mining Corp.) reports its annual results on Form 10-K, highlighting its shift towards a blockchain-based platform for the cannabis industry and its challenges as a going concern.

KonaTel, Inc. announces a net income of $4.49 million for the year ended December 31, 2024, driven by the sale of a 49% membership interest in IM Telecom to Excess Telecom.

BioAdaptives, Inc. reports its 10-K filing for the year ended December 31, 2024, highlighting a strategic shift towards natural health products and medical devices, with new product launches expected in 2025.

Windtree Therapeutics reports its 2024 10-K filing, highlighting financial uncertainties alongside progress in its cardiovascular and oncology programs.

Omnitek Engineering Corp. reports a slight decrease in revenue and a reduced net loss for the fiscal year ended December 31, 2024, while acknowledging ongoing concerns about its ability to continue as a going concern.

Matinas BioPharma's 10-K filing details its capital structure, strategic shift towards partnering for MAT2203, and ongoing efforts to explore strategic alternatives.

Moveix Inc.'s Form 10-K filing reveals the company's continued efforts to identify and acquire an operating business amidst financial uncertainties and a going concern warning.

XWELL, Inc. reports a 13% increase in total revenue for 2024, driven by Naples Wax acquisition and XpresSpa's touchless locations, while addressing going concern doubts and material weaknesses in internal controls.

TruGolf Holdings provides a detailed overview of its capital stock, governance structure, and risk factors in its latest 10-K filing.

Broad Capital Acquisition Corp.'s 10-K filing reveals a net loss, termination of the Openmarkets merger, and substantial doubt about its ability to continue as a going concern.

Southport Acquisition Corporation's 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite a proposed merger with Angel Studios.

Nuburu's 10-K filing reveals substantial losses, a shift in business strategy following a foreclosure, and a focus on strategic acquisitions to diversify its asset base.

MIRA Pharmaceuticals files an amendment to its annual report on Form 10-K to include a policy regarding the recovery of erroneously awarded compensation.

GameSquare Holdings' 2024 10-K filing reveals significant revenue growth due to strategic acquisitions, but also highlights material weaknesses in internal controls and a net loss.

Aimfinity Investment Corp. I amends its charter to extend the period for completing a business combination, allowing for up to nine additional one-month extensions.

Slam Corp's 10-K filing reveals substantial doubt about its ability to continue as a going concern as it navigates challenges in completing its initial business combination with Lynk Global.

Vaccinex's 10-K filing reveals a clinical-stage biotech company prioritizing Alzheimer's disease treatment while navigating financial challenges and strategic partnerships.